Global Down Syndrome

Issue 2 of 4 - 2017

Issue link: http://viewer.e-digitaledition.com/i/842481

Contents of this Issue

Navigation

Page 10 of 31

produce whole genome sequences for a population of 1,000 children with Down syndrome to better understand how genetic variation relates to differences in cognitive ability. "This will allow us to correlate genetic variation with variation in cognitive ability and the mother's health experience during pregnancy and the early months of a child's life," Dr. Reeves said. Finally, he is creating a new, better mouse model for preclinical studies of Down syndrome. "The Ts65Dn mouse model was the workhorse for the Down syndrome research community for two decades but is now dated," he said. "Can we make a better model? The answer is yes. We have one and are characterizing it now." That his research has the potential to improve the lives of people with Down syndrome is never far from Dr. Reeves' mind. "I spend a lot of time with families, which is very rewarding," he said. "I pick and choose which projects we're going to do based substantially on what I hear about the challenges their family members with Down syndrome are facing." FIGHTING FOR FUNDING The quality and promise of Dr. Reeves' work helped spare him from devastating funding cuts by the Eunice Kennedy Shriver National Institute of Child Health and Human Development in 2001 — reductions that occurred, in part, because of leadership's belief that Down syndrome was a lost cause. Many researchers lost their careers or changed their areas of focus, but Dr. Reeves pushed on with his work. He now belongs to the scientific advisory boards of several research and advocacy organizations, including the Linda Crnic Institute for Down Syndrome, which receives funding from Global Down Syndrome Foundation, and the LuMind Research Down Syndrome Foundation. "Down syndrome is still grossly underfunded compared to other conditions or diseases that cause cognitive problems," he said. "That's why foundations are so important. Global has taken a different path, which is to develop a critical mass of investigators at one institution. They are one of few foundations that give money to research in meaningful terms." LEAVING A LEGACY As Dr. Reeves looks toward the home stretch of his career, his mind increasingly turns to the next generation of young investigators. He is dedicated to advancing the field as President of the Trisomy 21 Research Society. "For me, the surest sign of success would be if 15 years after I retire, my name were to come up rarely, in a historical context," Dr. Reeves said. "That would mean the next generation had moved Down syndrome research forward." Roger Reeves, Ph.D., (second row, second from the lef t) at the Sie Family Down Syndrome "Call to Action" Symposium in Januar y 2006 GLOBALDOWNSYNDROME.ORG 11 GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - Issue 2 of 4 - 2017